SalvaRx Group Plc

SalvaRx Group Plc

Health CarePharmaceuticals & Biotechnology
  • Price (GBX)31.25
  • Today's Change0.75 / 2.46%
  • Shares traded0.00
  • 1 Year change-5.30%
  • Beta0.1909
Data delayed at least 20 minutes, as of Oct 16 2017 11:39 BST.
More ▼

Key statistics

On Monday, SalvaRx Group Plc (SALV:LSE) closed at 31.25, 15.74% above the 52 week low of 27.00 set on Mar 07, 2017.
52-week range
27.00Mar 07 201747.09Jun 21 2017
Previous close30.50
Average volume7.03k
Shares outstanding36.47m
Free float5.96m
P/E (TTM)--
Market cap11.12m GBP
EPS (TTM)-0.0467
Data delayed at least 20 minutes, as of Oct 16 2017 11:39 BST.
More ▼

Investors Chronicle View

The last IC recommendation on SalvaRx Group Plc shares was Sell at 27.00 on 20 Sep 2013Read the full article
© Thomson Reuters Click for restrictions
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.
Markit Short Selling Activity © Markit. All rights reserved.
Although Markit has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of Markit on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.